Article Type

1 - 15 of 93 Results       Clear All

Heart Defects Affect 40,000 US Babies Every Year—But Cutting Edge AI and Stem Cell Tech Will Save Lives and Even Cure Them in the Womb

Gladstone in the News November 8, 2024

Heart Defects Affect 40,000 US Babies Every Year—But Cutting Edge AI and Stem Cell Tech Will Save Lives and Even Cure Them in the Womb

New York Post—Top health researchers from the Murdoch Children’s Research Institute in Australia have teamed with those from Gladstone Institutes in San Francisco on a new program to develop cutting-edge technologies to treat the underlying causes of childhood heart disease more effectively.

Institutional News Cardiovascular Disease

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times

Deepak Srivastava
Article May 10, 2024

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times

The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.

Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava Lab

A.I. Is Learning What It Means to Be Alive

Gladstone in the News March 10, 2024

A.I. Is Learning What It Means to Be Alive

New York Times—Several new artificial intelligence-powered programs are setting their sights on the fundamentals of biology. They are not simply tidying up the information that biologists are collecting. They are making discoveries about how genes work and how cells develop. Gladstone Assistant Investigator Christina Theodoris shares her journey of creating the deep learning model GeneFormer.

Cardiovascular Disease Theodoris Lab AI Big Data

Heart-to-Heart Connection: Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life

Exploratorium hero image
Article February 8, 2024

Heart-to-Heart Connection: Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life

At San Francisco’s Exploratorium, visitors sync their heartbeat with living heart cells; the first-of-its-kind exhibit was created through the museum’s long-running partnership with scientists at Gladstone Institutes.

News Release Stem Cells/iPSCs Conklin Lab Yamanaka Lab Cardiovascular Disease Research (Publication)

Genetic Mechanisms Linking Maternal Diabetes and Birth Defects Uncovered

Gladstone in the News December 3, 2023

Genetic Mechanisms Linking Maternal Diabetes and Birth Defects Uncovered

Genetic Engineering & Biotechnology News—In addition to genetic changes, environmental factors are associated with the development of birth defects. A new study led by Deepak Srivastava, president of Gladstone Institutes, reveals how maternal diabetes alters a small subset of cells in the developing heart in a way that can lead to congenital heart defects.

Gladstone Experts Congenital Heart Disease Diabetes Cardiovascular Disease Srivastava Lab Single Cell

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

Gladstone in the News November 7, 2023

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media